U.S. biotech company Moderna Inc said on Monday that its vaccine candidate was 94.5% effective in preventing COVID-19, based on Phase 3 trials. It comes just a week after Pfizer Inc and BioNTech SE have announced that their vaccine candidate is more than 90% effective in preventing COVID-19. “… the independent Data Security Oversight Board (DSMB) appointed by the NIH for the Phase 3 study of mRNA-1273, its COVID-19 vaccine candidate, Moderna informed that the trial met the statistical criteria pre-specified in the study protocol for efficacy, with a vaccine efficacy of 94.5 percent, “the company said in a statement. This study, known as COVE study, recruited more than 30,000 participants in the United States, he added. “This is a pivotal moment in the development of our COVID-19 vaccine candidate. Since the beginning of January, we have chased this virus with the intention of protecting as many people as possible in the world “, said Stéphane Bancel, CEO of Moderna, #Moderna #StephaneBancel #PfizerInc #BioNTech #DataSafetyMonitoringBoard #DSMB # COVID19Vaccine HyBiz Tv is the most watched digital commercial channel in India with over 1 million regular viewers.In the 10 years of its existence, HyBiz Tv has provided a platform for companies to promote, showcase and broadcast their products and services. Corporate videos, promotional videos, interviews, commercials, event coverage, relevant news, meaningful discussions on contemporary topics have given audiences relevant content which has contributed to the rapid growth of audience. Customers in Telugu States and across the country have reaped rich dividends by hiring HyBiz Tv and now it has spread across the country .. ► Watch more business videos on India’s leading online business channel ► Like us on Facebook: ► Watch more videos on ► Subscribe to HYBIZTV channel: goo.gl/EEXqfu ►Follow- us on Twitter.
#Moderna #announces #COVID19 #vaccine #candidate #effective #Hybiz